Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 69 EP applications Regina Vögeli-Lange has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 27, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710850

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, C07D 519/00, C07D 487/04, A61P 37/00, A61P 29/00, A61P 19/00, A61P 17/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
PATENT GRANTED
EP12711093

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, C07F 9/11, C07D 487/04, A61P 37/00, A61P 29/00, A61P 19/00, A61P 17/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
The patent has been granted
EP12710852

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, C07D 519/00, C07D 487/04, A61P 37/00, A61P 29/00, A61P 19/00, A61P 17/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
PATENT GRANTED
EP12775886

SELECTIVE NR2B ANTAGONISTS

IPC classification:
A61K 31/4709, C07D 471/04, C07D 417/14, C07D 417/12, C07D 413/14, C07D 413/12, C07D 413/08, C07D 413/06, C07D 403/08, C07D 401/12, C07D 271/113, A61P 25/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP12783457

A COMPOUND FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/55, C07D 487/04, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12809969

CO-PROCESSING METHOD AND FORMULATION FOR HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND EXCIPIENTS

IPC classification:
A61K 9/20, A61K 9/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13700828

HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/517, A61K 31/5025, A61K 31/498, A61K 31/4709, A61K 31/4439, A61K 31/443, A61K 31/4427, C07D 487/04, C07D 471/10, C07D 471/04, C07D 417/14, C07D 417/04, C07D 413/14, C07D 413/04, A61P 29/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
GRANT OF PATENT INTENDED
EP13700833

THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/4439, C07D 417/14, C07D 417/04, A61P 29/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700829

TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/506, A61K 31/5025, A61K 31/498, A61K 31/497, A61K 31/496, A61K 31/4545, A61K 31/444, A61K 31/4439, A61K 31/437, C07D 487/04, C07D 471/04, C07D 417/14, C07D 417/04, C07D 413/14, C07D 413/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13701178

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 45/06, A61K 31/4178, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION IN PROGRESS
EP13704340

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, C07D 401/12, C07D 251/52, A61P 31/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704338

NOVEL COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/506, A61K 31/4178, C07D 405/14, C07D 405/04, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13705076

METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND

IPC classification:
C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13707493

C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/58, A61K 31/575, C07J 63/00, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13705712

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4375, C07D 471/04, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13706896

PROCESS FOR RESOLVING CYCLOPROPYL DIESTERS

IPC classification:
C12P 41/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13708603

N- (5S, 6S, 9R) - 5 -AMINO- 6 - (2, 3 - DIFLUOROPHENYL) -6, 7, 8, 9 - TETRAHYDRO - 5H - CYCLOHEPTA [B]PYRIDIN-9 -YL- 4 - (2 - OXO-2, 3 - DIHYDRO - 1H- IMIDAZO [4, 5 -B]PYRIDIN - 1 - YL) PIPERIDINE - 1 - CARBOXYLATE, HEMISULFATE SALT

IPC classification:
A61K 31/437, C07D 471/04, A61P 25/00, A61P 11/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13710203

ARYL ETHER-BASE KINASE INHIBITORS

IPC classification:
A61K 31/444, C07D 491/04, A61P 25/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13710940

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, C07D 487/04, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13713039

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
A61K 31/4745, C07D 471/04, A61P 25/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13714178

BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/343, C07D 405/14, C07D 307/84, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13722217

SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

IPC classification:
A61K 31/4709, A61K 9/48, A61P 31/14
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13722251

ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

IPC classification:
A61K 31/4709, A61K 9/20, A61P 31/14
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13722947

C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/56, C07J 63/00, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13725545

SULFILIMINE AND SULPHOXIDE METHODS FOR PRODUCING FESTINAVIR

IPC classification:
C07D 407/04, C07D 309/10, C07D 307/20
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13739922

IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/53, C07D 487/04, A61P 35/00, A61P 19/02, A61P 17/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
The patent has been granted
EP13740485

NOVEL METHODS AND INTERMEDIATES FOR THE PREPARATION OF (4BS,5AR)-12-CYCLOHEXYL-N-(N,N-DIMETHYLSULFAMOYL)-3-METHOXY-5A-((1 R,5S) -3-METHYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBONYL)-4B,5,5A,6-TETRAHYDROBENZO [3,4]CYCLOPROPA[5,6]AZEPINO[1,2-A]INDOLE-9-CARBOXAMIDE

IPC classification:
A61K 31/55, C07D 519/00, C07D 487/04, A61P 31/14
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13744927

ARYL LACTAM KINASE INHIBITORS

IPC classification:
A61K 31/4375, C07D 471/04, A61P 25/28, A61P 25/16, A61P 25/02
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13747625

DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/439, C07D 487/18, C07D 487/08, C07D 471/08, C07D 401/04, A61P 7/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13747624

DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/439, C07D 487/18, C07D 471/08, C07D 401/04, A61P 7/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
PATENT GRANTED
EP13750479

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, C07D 498/16, C07D 487/16, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13762679

IMIDAZOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, C07D 487/04, A61P 35/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13748452

PIPERIDINE AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/454, A61K 31/437, C07D 471/04, C07D 401/06, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13753225

TRICYCLIC AMIDINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/553, A61K 31/551, C07D 471/04, C07D 413/12, C07D 403/12, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13748451

TRICYCLIC ALKENE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/4545, A61K 31/454, A61K 31/437, C07D 471/04, C07D 401/14, C07D 401/06, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770803

SUBSTITUTED 1,5-BENZODIAZEPINONE COMPOUNDS

IPC classification:
A61K 31/5513, C07D 401/04, C07D 243/24, A61P 35/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770806

BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AS NOTCH INHIBITORS

IPC classification:
A61K 31/55, C07F 9/38, C07D 401/04, C07D 243/26, C07D 243/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770811

FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS

IPC classification:
A61K 31/5513, C07D 491/04, C07D 413/14, C07D 413/12, C07D 401/12, C07D 401/04, C07D 243/24, A61P 35/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770809

TRICYCLIC HETEROCYCLIC COMPOUNDS AS NOTCH INHIBITORS

IPC classification:
A61K 31/55, C07D 498/04, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13783174

GUANIDINE SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/496, A61K 31/4745, A61K 31/4743, A61K 31/4725, C07D 513/04, C07D 495/04, C07D 401/14, C07D 401/06, C07D 217/26, A61P 7/02
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP13780287

CRYSTALLINE FORMS OF A FACTOR XIA INHIBITOR

IPC classification:
A61K 31/496, C07D 401/14, A61P 7/02
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
The patent has been granted
EP12781012

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/4178, C07D 405/14, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13789670

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, C07K 5/083, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13789680

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, C07K 5/083, C07K 5/08, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13789672

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, C07K 5/083, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13789457

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/12, C07K 5/12, C07D 487/12, C07D 487/04, A61P 31/22
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13785706

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
C07D 498/22, C07D 498/12, C07D 498/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13783188

TETRAHYDROIMDIDAZOPYRAZINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4985, C07D 487/04, A61P 25/06, A61P 11/06
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13818937

NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 / INHIBITORS

IPC classification:
A61K 31/5025, C07D 487/04, A61P 35/00, A61P 25/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP12806857

4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

IPC classification:
C07D 417/14, C07D 417/12, C07D 417/10, C07D 417/04, A61P 25/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13818939

PYRAZOLE SUBSTITUTED IMIDAZOPYRAZINES AS CASEIN KINASE 1 D/E INHIBITORS

IPC classification:
A61K 31/5025, C07D 487/04, A61P 37/00, A61P 25/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14701637

MACROCYCLIC BENZOFURAN AND AZABENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/34, C07D 498/04, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP14704024

GUANIDINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, C07D 403/14, C07D 403/12, C07D 251/52, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14704444

AMMONIUM DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, C07D 251/52, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14706201

5H-CHROMENO[3,4-C]PYRIDINES AS INHIBITORS OF ADAPTOR ASSOCIATED KINASE 1 (AAK1)

IPC classification:
A61P 25/02, A61P 25/18, A61P 25/16, A61P 25/28, A61K 31/4375, C07D 491/052
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14712831

PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS

IPC classification:
A61P 29/00, A61P 11/00, A61P 9/00, A61K 31/4155, A61K 31/415, C07D 487/04, C07D 409/12, C07D 401/12, C07D 231/12, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14710732

PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS

IPC classification:
A61P 37/00, A61P 29/00, A61P 9/00, A61K 31/415, C07D 513/04, C07D 405/12, C07D 401/12, C07D 231/12, C07D 217/12, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14715470

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/00, A61P 31/14, C07K 5/10, C07K 5/103
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14727649

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS

IPC classification:
G01N 33/68, A61K 38/12, C07K 7/08, C07K 7/56
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14741757

TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS

IPC classification:
A61P 11/00, A61P 9/00, A61K 31/519, C07D 498/04, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13740435

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61P 31/14, A61K 31/4178, A61K 31/4164, A61K 45/06
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14745008

ARYL AMIDE KINASE INHIBITORS

IPC classification:
A61K 31/422, C07D 213/62, C07D 213/61, C07D 213/16, C07D 285/08, C07D 277/20, C07D 263/30, C07D 487/04, C07D 249/06, C07D 417/12, C07D 413/12, C07D 237/08, C07D 233/54, C07D 231/12, C07D 213/72
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14748036

COMBINATIONS COMPRISING TRICYCLOHEXADECAHEXAENE DERIVATIVES FOR USE IN THE TREATMENT OF HEPATITIS C VIRUS

IPC classification:
A61P 31/14, C07D 235/04, A61K 31/4184, A61K 31/4178, A61K 31/4164
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14747245

COMBINATIONS COMPRISING BIPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF HCV

IPC classification:
A61P 31/14, C07D 295/00, C07D 261/02, C07D 233/00, A61K 31/5377, A61K 31/496, A61K 31/421, A61K 31/4178, A61K 31/4164
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP15183086

PROCESS FOR SYNTHESIZING SUBSTITUTED ISOQUINOLINES

IPC classification:
C07D 217/24
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP14755304

IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA

IPC classification:
A61P 25/28, A61P 25/24, A61P 25/18, A61P 25/16, A61P 25/04, A61K 31/5025, A61K 31/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14786421

HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT

IPC classification:
A61K 9/24
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14792665

PYRROLOTRIAZINE KINASE INHIBITORS

IPC classification:
A61P 25/28, A61P 25/18, A61P 25/02, A61P 25/00, A61K 31/53
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP12704954

COMPOUNDS FOR THE REDUCTION OF ss-AMYLOID PRODUCTION

IPC classification:
A61P 25/28, A61K 31/519, A61K 31/517, C07D 491/04, C07D 401/04, C07D 239/70
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Annabel Rose Beacham, Dehns Ltd
Status:
PATENT GRANTED

Please Sign in to use this feature